Hexachlorobenzene-induced alterations of rat hepatic microsomal membrane function. 1998

A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
Department of Human Biochemistry, School of Medicine, University of Buenos Aires, Argentina.

The time and dose-dependent effects of the in vivo administration of hexachlorobenzene (HCB), on hepatic microsomal membrane functions, were studied in female Wistar rats. Administration of HCB (100 mg/100 g b.w.) resulted in time-dependent decreases in the activity of two membrane-bound enzymes: 5'nucleotidase and Na+/K+ ATPase. HCB was found to cause a significant rise in protein tyrosine kinase (PTK) activity during the early stages of intoxication (day 2), followed by a significant decrease at 10 days, returning to control levels after 20 days of treatment. A stimulatory effect of HCB on in vitro endogenous microsomal protein phosphorylation was observed from 2 days of intoxication up to 30 days of treatment, with an important stimulation of phosphorylation at 5 days. Administration of HCB (100 mg/100 g b.w.) for 10 days caused a 50% reduction in epidermal growth factor receptor (EGF-R) ligand binding. The effects of known specific inhibitors of protein phosphatases on endogenous protein phosphorylation were studied. HCB affected the labelling of several bands, as well as the 5'nucleotidase and PTK activities, in a dose-dependent manner. In conclusion, this study indicated that the in vivo administration of HCB results in a significant alteration of membrane function.

UI MeSH Term Description Entries
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006581 Hexachlorobenzene An agricultural fungicide and seed treatment agent. HCB
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
December 1979, American journal of veterinary research,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
August 1974, Biochemical pharmacology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
September 1987, Toxicology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
January 1975, Journal of agricultural and food chemistry,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
November 1975, Biochemical pharmacology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
November 1972, Biochemical pharmacology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
January 1988, Journal of biochemical toxicology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
December 1982, The Biochemical journal,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
January 1985, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
A S Randi, and H A Sancovich, and A M Ferramola de Sancovich, and A Loaiza, and L Krawiec, and D L Kleiman de Pisarev
November 1988, Biochemical pharmacology,
Copied contents to your clipboard!